The Serum Institute of India (SII) on Thursday applied to the Drug Controller General of India (DCGI) seeking permission for a test license to manufacture Russia's Sputnik V COVID-19 vaccine.
Further details awaited.
The Serum Institute of India (SII) on Thursday applied to the Drug Controller General of India (DCGI) seeking permission for a test license to manufacture Russia's Sputnik V COVID-19 vaccine.
Further details awaited.